XML 49 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 49,511us-gaap_CashAndCashEquivalentsAtCarryingValue $ 23,122us-gaap_CashAndCashEquivalentsAtCarryingValue
Marketable securities available-for-sale 73,141us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent 166,254us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent
Accounts receivable 727us-gaap_AccountsReceivableNetCurrent 1,627us-gaap_AccountsReceivableNetCurrent
Prepaid expenses and other current assets 4,058us-gaap_PrepaidExpenseAndOtherAssetsCurrent 1,375us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 127,437us-gaap_AssetsCurrent 192,378us-gaap_AssetsCurrent
Property and equipment, net 7,924us-gaap_PropertyPlantAndEquipmentNet 8,706us-gaap_PropertyPlantAndEquipmentNet
Goodwill 2,277us-gaap_Goodwill 2,579us-gaap_Goodwill
Restricted cash 632us-gaap_RestrictedCashAndCashEquivalentsNoncurrent 662us-gaap_RestrictedCashAndCashEquivalentsNoncurrent
Other assets 20us-gaap_OtherAssetsNoncurrent 297us-gaap_OtherAssetsNoncurrent
Total assets 138,290us-gaap_Assets 204,622us-gaap_Assets
Current liabilities:    
Accounts payable 1,159us-gaap_AccountsPayableCurrent 1,901us-gaap_AccountsPayableCurrent
Accrued research and development 6,938dvax_AccruedResearchAndDevelopmentExpensesCurrent 2,402dvax_AccruedResearchAndDevelopmentExpensesCurrent
Accrued liabilities 6,317us-gaap_AccruedLiabilitiesCurrent 5,764us-gaap_AccruedLiabilitiesCurrent
Deferred revenues 5,865us-gaap_DeferredRevenueCurrent 6,125us-gaap_DeferredRevenueCurrent
Total current liabilities 20,279us-gaap_LiabilitiesCurrent 16,192us-gaap_LiabilitiesCurrent
Deferred revenues, net of current portion 6,900us-gaap_DeferredRevenueNoncurrent 1,173us-gaap_DeferredRevenueNoncurrent
Long term debt 9,559us-gaap_LongTermDebt  
Other long-term liabilities 1,070us-gaap_OtherLiabilitiesNoncurrent 963us-gaap_OtherLiabilitiesNoncurrent
Total liabilities 37,808us-gaap_Liabilities 18,328us-gaap_Liabilities
Commitments and contingencies      
Stockholders’ equity:    
Common stock: $0.001 par value; 69,500 and 35,000 shares authorized at December 31, 2014 and 2013, respectively; 26,307 and 26,280 shares issued and outstanding at December 31, 2014 and 2013, respectively 26us-gaap_CommonStockValue 263us-gaap_CommonStockValue
Additional paid-in capital 695,058us-gaap_AdditionalPaidInCapitalCommonStock 688,390us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive loss (1,669)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (148)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (592,933)us-gaap_RetainedEarningsAccumulatedDeficit (502,211)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders’ equity 100,482us-gaap_StockholdersEquity 186,294us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity 138,290us-gaap_LiabilitiesAndStockholdersEquity 204,622us-gaap_LiabilitiesAndStockholdersEquity
Series B Convertible Preferred Stock    
Stockholders’ equity:    
Preferred stock: $0.001 par value Authorized: 5,000 shares; Issued and outstanding: Series B Convertible Preferred Stock — 43 shares at December 31, 2014 and 2013